New program aims to ease burden on schizophrenia caregivers
NCT ID NCT07173192
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests an individual empowerment program for primary caregivers of people with schizophrenia. The program includes six training sessions to help caregivers cope better. Researchers will measure whether it reduces care burden and improves psychological well-being and self-efficacy compared to standard discharge education. The study involves 66 caregivers in Turkey.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
individual empowerment program (behavioral intervention)
What this could lead to
If it works, this program could provide a simple, low-cost way to improve the mental health and coping skills of people caring for loved ones with schizophrenia.
What could go wrong
This is a small, early-stage study with only 66 participants, so results may not apply to all caregivers. The program is behavioral, so benefits depend on individual engagement and may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istanbul Arel University
Istanbul, Cevizlibağ, 34010, Turkey (Türkiye)